Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Transplantation Proceedings
|
December 1, 1995
Identification of quality-of-life outcomes distinguishing diabetic kidney-alone and pancreas-kidney recipients
D K Hathaway, M S Hartwig, D B Crom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Orbital development in long-term survivors of retinoblastoma
S C Kaste, G Chen, J Fontanesi, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
February 19, 2000
Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors
D B Crom, D K Chathaway, E A Tolley, et al.
Cancer Treatment Reports
|
January 1, 1983
Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin
C B Pratt, D B Crom, J Wallenberg, et al.
Medical and Pediatric Oncology
|
July 13, 2002
Multi-component behavioral intervention to promote health protective behaviors in childhood cancer survivors: the protect study
Melissa M Hudson, V L Tyc, D K Srivastava, et al.
Investigational New Drugs
|
January 1, 1986
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors
C B Pratt, J A Sinkule, E Etcubanas, et al.
Medical and Pediatric Oncology
|
January 1, 1989
Malignancy in the neonate
D B Crom, J A Wilimas, A A Green, et al.
Medical and Pediatric Oncology
|
January 1, 1997
Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors
D B Crom, S C Kaste, D G Tubergen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate
W R Crom, C B Pratt, A A Green, et al.
Cancer
|
October 15, 1985
Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicin
C B Pratt, J E Champion, N Senzer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Transplantation Proceedings
|
December 1, 1995
Identification of quality-of-life outcomes distinguishing diabetic kidney-alone and pancreas-kidney recipients
D K Hathaway, M S Hartwig, D B Crom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Orbital development in long-term survivors of retinoblastoma
S C Kaste, G Chen, J Fontanesi, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
February 19, 2000
Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors
D B Crom, D K Chathaway, E A Tolley, et al.
Cancer Treatment Reports
|
January 1, 1983
Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin
C B Pratt, D B Crom, J Wallenberg, et al.
Medical and Pediatric Oncology
|
July 13, 2002
Multi-component behavioral intervention to promote health protective behaviors in childhood cancer survivors: the protect study
Melissa M Hudson, V L Tyc, D K Srivastava, et al.
Investigational New Drugs
|
January 1, 1986
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors
C B Pratt, J A Sinkule, E Etcubanas, et al.
Medical and Pediatric Oncology
|
January 1, 1989
Malignancy in the neonate
D B Crom, J A Wilimas, A A Green, et al.
Medical and Pediatric Oncology
|
January 1, 1997
Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors
D B Crom, S C Kaste, D G Tubergen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate
W R Crom, C B Pratt, A A Green, et al.
Cancer
|
October 15, 1985
Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicin
C B Pratt, J E Champion, N Senzer, et al.
Page
of 3